MPLX LP (MPLX) director receives 218.82-unit equity grant
Rhea-AI Filing Summary
MPLX LP (MPLX) reported that a director received an additional equity award in the form of common units. Reporting person Christine S. Breves acquired 218.82 common units of limited partner interests at a stated price of $0.00 per unit, increasing her direct holdings to 15,038.282 units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 218.82 shares
Net Buy
1 txn
Insider
Breves Christine S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Units (Limited Partner Interests) | 218.82 | $0.00 | $0.00 |
Holdings After Transaction:
Common Units (Limited Partner Interests) — 15,038.282 shares (Direct)
Key Figures
Units acquired: 218.8200 units
Price per unit: $0.0000
Units owned after transaction: 15038.2820 units
3 metrics
Units acquired
218.8200 units
Grant, award, or other acquisition of Common Units on 2026-08-14
Price per unit
$0.0000
Stated transaction price per Common Unit for the award
Units owned after transaction
15038.2820 units
Total direct holdings reported for Christine S. Breves after the award
Key Terms
Common Units (Limited Partner Interests), general partner, Rule 10b5-1
3 terms
Common Units (Limited Partner Interests) financial
"security_title: Common Units (Limited Partner Interests)"
general partner financial
"MPLX GP LLC, the general partner of the Issuer"
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction in MPLX (MPLX) did Christine S. Breves report?
Christine S. Breves reported acquiring 218.82 common units of MPLX LP as a grant or award. These are Common Units (Limited Partner Interests) and reflect additional equity compensation rather than an open-market purchase.
How many MPLX (MPLX) units does Christine S. Breves hold after this transaction?
After the reported grant, Christine S. Breves directly holds 15,038.282 common units of MPLX LP. This figure represents her total direct ownership reported following the August 14, 2026 transaction.
What was the price per unit in the latest MPLX (MPLX) insider award to Christine S. Breves?
The award to Christine S. Breves was reported at a price of $0.00 per unit. This indicates the transaction was a grant or award of equity, not a market purchase for cash consideration.
Was the recent MPLX (MPLX) insider transaction under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not selected. This means the reported acquisition of 218.82 units by Christine S. Breves was not affirmed as being made under a Rule 10b5-1 trading plan.
What role does the reporting person play in relation to MPLX (MPLX)?
The reporting person, Christine S. Breves, is a director of MPLX GP LLC, the general partner of MPLX LP. MPLX LP is managed by the directors and executive officers of MPLX GP LLC.
AI-generated analysis. How Rhea-AI works. Not financial advice.